Synthesis, modelling, and μ-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes

G. A. Pinna, G. Murineddu, M. M. Curzu, S. Villa, P. Vianello, P. A. Borea, S. Gessi, L. Toma, D. Colombo, G. Cignarella

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

A series of N-3-arylpropenyl-N-9-propionyl-3,9-diazabicyclo[3.3.1]nonanes (1a-g) and of reverted N-3-propionyl-N-9-arylpropenyl isomers (2a-g), as homologues of the previously reported analgesic 3,8-diazabicyclo[3.2.1]octanes (I-II), were synthesized and evaluated for the binding affinity towards opioid receptor subtypes μ, δ and κ. Compounds 1a-g and 2a-g exhibited a strong selective μ-affinity with Ki values in the nanomolar range, which favourably compared with those of I and II. In addition, contrary to the trend observed for DBO-I, II, the μ-affinity of series 2 is markedly higher than that of the isomeric series 1. This aspect was discussed on the basis of the conformational studies performed on DBN which allowed hypotheses on the mode of interaction of these compounds with the μ receptor.

Original languageEnglish
Pages (from-to)553-562
Number of pages10
JournalFarmaco
Volume55
Issue number8
DOIs
Publication statusPublished - 2000

Fingerprint

Octanes
Opioid Receptors
Analgesics
nonane

Keywords

  • μ-Affinity
  • Diazabicyclononanes
  • Modelling

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmaceutical Science

Cite this

Synthesis, modelling, and μ-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes. / Pinna, G. A.; Murineddu, G.; Curzu, M. M.; Villa, S.; Vianello, P.; Borea, P. A.; Gessi, S.; Toma, L.; Colombo, D.; Cignarella, G.

In: Farmaco, Vol. 55, No. 8, 2000, p. 553-562.

Research output: Contribution to journalArticle

Pinna, GA, Murineddu, G, Curzu, MM, Villa, S, Vianello, P, Borea, PA, Gessi, S, Toma, L, Colombo, D & Cignarella, G 2000, 'Synthesis, modelling, and μ-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes', Farmaco, vol. 55, no. 8, pp. 553-562. https://doi.org/10.1016/S0014-827X(00)00036-7
Pinna, G. A. ; Murineddu, G. ; Curzu, M. M. ; Villa, S. ; Vianello, P. ; Borea, P. A. ; Gessi, S. ; Toma, L. ; Colombo, D. ; Cignarella, G. / Synthesis, modelling, and μ-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes. In: Farmaco. 2000 ; Vol. 55, No. 8. pp. 553-562.
@article{293950382e1243e2abed5e2daede081e,
title = "Synthesis, modelling, and μ-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes",
abstract = "A series of N-3-arylpropenyl-N-9-propionyl-3,9-diazabicyclo[3.3.1]nonanes (1a-g) and of reverted N-3-propionyl-N-9-arylpropenyl isomers (2a-g), as homologues of the previously reported analgesic 3,8-diazabicyclo[3.2.1]octanes (I-II), were synthesized and evaluated for the binding affinity towards opioid receptor subtypes μ, δ and κ. Compounds 1a-g and 2a-g exhibited a strong selective μ-affinity with Ki values in the nanomolar range, which favourably compared with those of I and II. In addition, contrary to the trend observed for DBO-I, II, the μ-affinity of series 2 is markedly higher than that of the isomeric series 1. This aspect was discussed on the basis of the conformational studies performed on DBN which allowed hypotheses on the mode of interaction of these compounds with the μ receptor.",
keywords = "μ-Affinity, Diazabicyclononanes, Modelling",
author = "Pinna, {G. A.} and G. Murineddu and Curzu, {M. M.} and S. Villa and P. Vianello and Borea, {P. A.} and S. Gessi and L. Toma and D. Colombo and G. Cignarella",
year = "2000",
doi = "10.1016/S0014-827X(00)00036-7",
language = "English",
volume = "55",
pages = "553--562",
journal = "Farmaco",
issn = "0014-827X",
publisher = "Societa chimica italiana",
number = "8",

}

TY - JOUR

T1 - Synthesis, modelling, and μ-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes

AU - Pinna, G. A.

AU - Murineddu, G.

AU - Curzu, M. M.

AU - Villa, S.

AU - Vianello, P.

AU - Borea, P. A.

AU - Gessi, S.

AU - Toma, L.

AU - Colombo, D.

AU - Cignarella, G.

PY - 2000

Y1 - 2000

N2 - A series of N-3-arylpropenyl-N-9-propionyl-3,9-diazabicyclo[3.3.1]nonanes (1a-g) and of reverted N-3-propionyl-N-9-arylpropenyl isomers (2a-g), as homologues of the previously reported analgesic 3,8-diazabicyclo[3.2.1]octanes (I-II), were synthesized and evaluated for the binding affinity towards opioid receptor subtypes μ, δ and κ. Compounds 1a-g and 2a-g exhibited a strong selective μ-affinity with Ki values in the nanomolar range, which favourably compared with those of I and II. In addition, contrary to the trend observed for DBO-I, II, the μ-affinity of series 2 is markedly higher than that of the isomeric series 1. This aspect was discussed on the basis of the conformational studies performed on DBN which allowed hypotheses on the mode of interaction of these compounds with the μ receptor.

AB - A series of N-3-arylpropenyl-N-9-propionyl-3,9-diazabicyclo[3.3.1]nonanes (1a-g) and of reverted N-3-propionyl-N-9-arylpropenyl isomers (2a-g), as homologues of the previously reported analgesic 3,8-diazabicyclo[3.2.1]octanes (I-II), were synthesized and evaluated for the binding affinity towards opioid receptor subtypes μ, δ and κ. Compounds 1a-g and 2a-g exhibited a strong selective μ-affinity with Ki values in the nanomolar range, which favourably compared with those of I and II. In addition, contrary to the trend observed for DBO-I, II, the μ-affinity of series 2 is markedly higher than that of the isomeric series 1. This aspect was discussed on the basis of the conformational studies performed on DBN which allowed hypotheses on the mode of interaction of these compounds with the μ receptor.

KW - μ-Affinity

KW - Diazabicyclononanes

KW - Modelling

UR - http://www.scopus.com/inward/record.url?scp=0034530169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034530169&partnerID=8YFLogxK

U2 - 10.1016/S0014-827X(00)00036-7

DO - 10.1016/S0014-827X(00)00036-7

M3 - Article

C2 - 11132733

AN - SCOPUS:0034530169

VL - 55

SP - 553

EP - 562

JO - Farmaco

JF - Farmaco

SN - 0014-827X

IS - 8

ER -